FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2198090250> ?p ?o ?g. }

• W2198090250 abstract "Idiopathic pulmonary fibrosis (IPF) is a rare and serious disease characterized by progressive lung-function loss. Limited evidence has been published on the impact of lung-function loss on subsequent patient outcomes. This study examined change in forced vital capacity (FVC) across IPF patients in the 6 months after diagnosis and its association with clinical and healthcare resource utilization (HRU) outcomes in a real-world setting in the U.S.A retrospective chart review was conducted of patients diagnosed with IPF by U.S. pulmonologists. Patient eligibility criteria included: 1) 40 years or older with a confirmed date of first IPF diagnosis with high-resolution computed tomography and/or lung biopsy between 01/2011 and 06/2013; 2) FVC results recorded at first diagnosis (±1 month) and at 6 months (±3 months) following diagnosis. Based on relative change in FVC percent predicted (FVC%), patients were categorized as stable (decline <5%), marginal decline (decline ≥5% and <10%), or significant decline (decline ≥10%). Physician-reported clinical and HRU outcomes were assessed from ~6 months post-diagnosis until the last contact date with the physician and compared between FVC% change groups. Multivariable Cox proportional-hazards models were constructed to assess risk of mortality, suspected acute exacerbation (AEx), and hospitalization post-FVC% change. Generalized estimating equations were used to account for multiple patients contributed by individual physicians.The sample included 490 IPF patients contributed by 168 pulmonologists. The mean (SD) age was 61 (11) years, 68% were male, and the mean (SD) baseline FVC% was 60% (26%). 250 (51%) patients were categorized as stable, 98 (20%) as marginal decline, and 142 (29%) as significant decline. The mean (SD) observation time was 583 (287) days. In both unadjusted analysis and multivariable models, significantly worse clinical outcomes and increased HRU were observed with greater lung-function decline.These findings suggest that nearly half of IPF patients experienced decline in FVC% within ~6 months following IPF diagnosis. Greater FVC% decline was associated with an increased risk of further IPF progression, suspected AEx, mortality, and higher rate of HRU. Management options that slow FVC decline may help improve future health outcomes in IPF." @default.
• W2198090250 created "2016-06-24" @default.
• W2198090250 creator A5007180084 @default.
• W2198090250 creator A5014132939 @default.
• W2198090250 creator A5052485494 @default.
• W2198090250 creator A5079001382 @default.
• W2198090250 creator A5089194015 @default.
• W2198090250 date "2015-12-01" @default.
• W2198090250 modified "2023-10-16" @default.
• W2198090250 title "Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis" @default.
• W2198090250 cites W1938547050 @default.
• W2198090250 cites W1954728404 @default.
• W2198090250 cites W1978199598 @default.
• W2198090250 cites W2004697839 @default.
• W2198090250 cites W2037681111 @default.
• W2198090250 cites W2058041469 @default.
• W2198090250 cites W2058234974 @default.
• W2198090250 cites W2095309945 @default.
• W2198090250 cites W2098305693 @default.
• W2198090250 cites W2100059970 @default.
• W2198090250 cites W2108981404 @default.
• W2198090250 cites W2110480206 @default.
• W2198090250 cites W2111256250 @default.
• W2198090250 cites W2115046554 @default.
• W2198090250 cites W2123137799 @default.
• W2198090250 cites W2125013258 @default.
• W2198090250 cites W2134215992 @default.
• W2198090250 cites W2138871107 @default.
• W2198090250 cites W2139890009 @default.
• W2198090250 cites W2140334695 @default.
• W2198090250 cites W2147335168 @default.
• W2198090250 cites W2154027222 @default.
• W2198090250 cites W2157869208 @default.
• W2198090250 cites W2161625871 @default.
• W2198090250 cites W2162214374 @default.
• W2198090250 cites W2163279300 @default.
• W2198090250 cites W2167383172 @default.
• W2198090250 cites W2233685176 @default.
• W2198090250 doi "https://doi.org/10.1186/s12890-015-0161-5" @default.
• W2198090250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4696269" @default.
• W2198090250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26714746" @default.
• W2198090250 hasPublicationYear "2015" @default.
• W2198090250 type Work @default.
• W2198090250 sameAs 2198090250 @default.
• W2198090250 citedByCount "51" @default.
• W2198090250 countsByYear W21980902502016 @default.
• W2198090250 countsByYear W21980902502017 @default.
• W2198090250 countsByYear W21980902502018 @default.
• W2198090250 countsByYear W21980902502019 @default.
• W2198090250 countsByYear W21980902502020 @default.
• W2198090250 countsByYear W21980902502021 @default.
• W2198090250 countsByYear W21980902502022 @default.
• W2198090250 countsByYear W21980902502023 @default.
• W2198090250 crossrefType "journal-article" @default.
• W2198090250 hasAuthorship W2198090250A5007180084 @default.
• W2198090250 hasAuthorship W2198090250A5014132939 @default.
• W2198090250 hasAuthorship W2198090250A5052485494 @default.
• W2198090250 hasAuthorship W2198090250A5079001382 @default.
• W2198090250 hasAuthorship W2198090250A5089194015 @default.
• W2198090250 hasBestOaLocation W21980902501 @default.
• W2198090250 hasConcept C126322002 @default.
• W2198090250 hasConcept C165637977 @default.
• W2198090250 hasConcept C177713679 @default.
• W2198090250 hasConcept C2777014857 @default.
• W2198090250 hasConcept C2777714996 @default.
• W2198090250 hasConcept C2778341716 @default.
• W2198090250 hasConcept C2780171596 @default.
• W2198090250 hasConcept C2908861384 @default.
• W2198090250 hasConcept C3018587741 @default.
• W2198090250 hasConcept C55520419 @default.
• W2198090250 hasConcept C71924100 @default.
• W2198090250 hasConcept C75603125 @default.
• W2198090250 hasConceptScore W2198090250C126322002 @default.
• W2198090250 hasConceptScore W2198090250C165637977 @default.
• W2198090250 hasConceptScore W2198090250C177713679 @default.
• W2198090250 hasConceptScore W2198090250C2777014857 @default.
• W2198090250 hasConceptScore W2198090250C2777714996 @default.
• W2198090250 hasConceptScore W2198090250C2778341716 @default.
• W2198090250 hasConceptScore W2198090250C2780171596 @default.
• W2198090250 hasConceptScore W2198090250C2908861384 @default.
• W2198090250 hasConceptScore W2198090250C3018587741 @default.
• W2198090250 hasConceptScore W2198090250C55520419 @default.
• W2198090250 hasConceptScore W2198090250C71924100 @default.
• W2198090250 hasConceptScore W2198090250C75603125 @default.
• W2198090250 hasFunder F4320306257 @default.
• W2198090250 hasIssue "1" @default.
• W2198090250 hasLocation W21980902501 @default.
• W2198090250 hasLocation W21980902502 @default.
• W2198090250 hasLocation W21980902503 @default.
• W2198090250 hasOpenAccess W2198090250 @default.
• W2198090250 hasPrimaryLocation W21980902501 @default.
• W2198090250 hasRelatedWork W2272059546 @default.
• W2198090250 hasRelatedWork W2555155415 @default.
• W2198090250 hasRelatedWork W2602828621 @default.
• W2198090250 hasRelatedWork W2610222453 @default.
• W2198090250 hasRelatedWork W2810931357 @default.
• W2198090250 hasRelatedWork W2906544732 @default.
• W2198090250 hasRelatedWork W3082109398 @default.
• W2198090250 hasRelatedWork W3087598739 @default.
• W2198090250 hasRelatedWork W3092981400 @default.

• next